New chief for UK medical research?

According to a linkurl:news report;http://www.nature.com/nature/journal/v449/n7159/full/449121a.html in today's Nature, Leszek Borysiewicz, a vaccinologist and deputy rector at Imperial College London, has been selected to become the chief executive of the UK Medical Research Council. Colin Blakemore, who has held the post since 2003, linkurl:plans;http://www.the-scientist.com/news/display/52932/ to step down at the end of this month. The changeover comes amidst a period of turbulence at the age

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
According to a linkurl:news report;http://www.nature.com/nature/journal/v449/n7159/full/449121a.html in today's Nature, Leszek Borysiewicz, a vaccinologist and deputy rector at Imperial College London, has been selected to become the chief executive of the UK Medical Research Council. Colin Blakemore, who has held the post since 2003, linkurl:plans;http://www.the-scientist.com/news/display/52932/ to step down at the end of this month. The changeover comes amidst a period of turbulence at the agency, marked most recently in July by linkurl:doubts;http://www.the-scientist.com/news/display/53454/ expressed by the House of Commons Select Committee on Science and Technology about the ability of John Chisholm, MRC chairman, to guide the agency. The MRC press office declined to confirm Borysiewicz's appointment - a spokesman told The Scientist that the Department for Innovation, Universities and Research is heading the search. A member of that department could not be reached for comment.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies